122 related articles for article (PubMed ID: 23624563)
1. TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Comabella M; Caminero AB; Malhotra S; Agulló L; Fernández O; Reverter F; Vandenbroeck K; Rodríguez-Antigüedad A; Matesanz F; Izquierdo G; Urcelay E; López-Larios A; Sánchez A; Otero S; Tintoré M; Montalban X
Neurology; 2013 May; 80(22):2010-6. PubMed ID: 23624563
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Agulló L; Malhotra S; Fissolo N; Montalban X; Comabella M
J Neuroimmunol; 2015 Dec; 289():12-20. PubMed ID: 26616867
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Ottoboni L; Frohlich IY; Lee M; Healy BC; Keenan BT; Xia Z; Chitnis T; Guttmann CR; Khoury SJ; Weiner HL; Hafler DA; De Jager PL
Neurology; 2013 Nov; 81(22):1891-9. PubMed ID: 24174586
[TBL] [Abstract][Full Text] [Related]
4. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
5. TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population.
Javor J; Shawkatová I; Ďurmanová V; Párnická Z; Čierny D; Michalik J; Čopíková-Cudráková D; Smahová B; Gmitterová K; Peterajová Ľ; Bucová M
Int J Immunogenet; 2018 Jul; ():. PubMed ID: 30009568
[TBL] [Abstract][Full Text] [Related]
6. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
Glossop JR; Dawes PT; Hassell AB; Mattey DL
J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
[TBL] [Abstract][Full Text] [Related]
7. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Hoffjan S; Okur A; Epplen JT; Wieczorek S; Chan A; Akkad DA
Int J Immunogenet; 2015 Apr; 42(2):106-10. PubMed ID: 25684197
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
[TBL] [Abstract][Full Text] [Related]
9. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
10. [Association analysis of cytokine receptors' genes polymorphisms with clinical features of multiple sclerosis].
Kulakova OG; Bashinskaya VV; Tsareva EY; Boyko AN; Favorova OO; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10. Vyp. 2):10-15. PubMed ID: 28139605
[TBL] [Abstract][Full Text] [Related]
11. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; de las Heras V; Barcina MG; Arroyo R; Alcina A; Fernandez O; Antigüedad A; Urcelay E; Vandenbroeck K
J Neuroimmunol; 2010 Jun; 223(1-2):100-3. PubMed ID: 20430450
[TBL] [Abstract][Full Text] [Related]
12. TNFRSF1A and MEFV mutations in childhood onset multiple sclerosis.
Blaschek A; V Kries R; Lohse P; Huss K; Vill K; Belohradsky BH; Heinen F; Müller-Felber W; Kümpfel T
Eur J Paediatr Neurol; 2018 Jan; 22(1):72-81. PubMed ID: 28927886
[TBL] [Abstract][Full Text] [Related]
13. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L
Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493
[TBL] [Abstract][Full Text] [Related]
14. TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina.
Kauffman MA; Gonzalez-Morón D; Garcea O; Villa AM
Mol Biol Rep; 2012 Jan; 39(1):117-21. PubMed ID: 21567205
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
17. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
[TBL] [Abstract][Full Text] [Related]
18. TNFRSF1A coding variants in multiple sclerosis.
Goris A; Fockaert N; Cosemans L; Clysters K; Nagels G; Boonen S; Thijs V; Robberecht W; Dubois B
J Neuroimmunol; 2011 Jun; 235(1-2):110-2. PubMed ID: 21565411
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
De Jager PL; Jia X; Wang J; de Bakker PI; Ottoboni L; Aggarwal NT; Piccio L; Raychaudhuri S; Tran D; Aubin C; Briskin R; Romano S; ; Baranzini SE; McCauley JL; Pericak-Vance MA; Haines JL; Gibson RA; Naeglin Y; Uitdehaag B; Matthews PM; Kappos L; Polman C; McArdle WL; Strachan DP; Evans D; Cross AH; Daly MJ; Compston A; Sawcer SJ; Weiner HL; Hauser SL; Hafler DA; Oksenberg JR
Nat Genet; 2009 Jul; 41(7):776-82. PubMed ID: 19525953
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
